News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest
CKLIFE SCIENCES (00775.HK) announced that its Polynoma will merge with TransCode Therapeutics (RNAZ.US), and they have entered into a share purchase and preferred stock financing a...
Reset
Send
The window will close in 5 seconds
CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest
Close
Recommend
11
Positive
16
Negative
6
 
SHORT SELL
 
STOCK INFO

CKLIFE SCIENCES (00775.HK)  -0.050 (-4.854%)    Short selling $640.32K; Ratio 3.478%   announced that its Polynoma will merge with TransCode Therapeutics (RNAZ.US)      , and they have entered into a share purchase and preferred stock financing agreement.

Initially, CKLIFE SCIENCES will hold about 9.1% of TransCode's shares and receive non-voting preferred stock. Once all preferred shares are approved for conversion, CKLIFE SCIENCES' stake in TransCode will rise to around 90.7%.

Alan Abel Yu Ying-choi, CKLIFE SCIENCES Vice Chairman, expects the preferred share conversion to be completed within the next 6-9 months. He believes this partnership will give the company a comprehensive portfolio of diversified R&D assets across early, mid, and late stages, increasing the number of its US-listed subsidiaries to two and helping broaden its financing channels.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-10-10 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.